Pfizer Inc.PFE

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · pfizer.com

Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines, vaccines, and consumer healthcare products. The company's portfolio spans oncology, immunology, cardiology, infectious diseases, and rare diseases, and includes blockbuster products such as Paxlovid, Comirnaty, Eliquis, and Prevnar. Pfizer is headquartered in New York City and operates in more than 125 countries worldwide.

Key ratios

Operating cash flow growth

-11.8%TTM

2025 -8.2%2024 46.5%2023 -70.3%

EPS growth

-59.8%TTM

2025 -3.6%2024 281.1%2023 -93.2%

FCF / Sales

17.2%TTM

2025 14.5%2024 15.5%2023 8.0%

Net margin

6.8%TTM

2025 12.4%2024 12.6%2023 3.6%

ROA

5.8%TTM

2025 5.7%2024 4.4%2023 1.9%

ROE

5.0%TTM

2025 8.9%2024 9.1%2023 2.4%

Revenue growth

-0.2%TTM

2025 -1.7%2024 6.8%2023 -41.1%

Recent news

Pfizer Declares Third-Quarter 2026 Dividend 2026-06-24 · Yahoo Finance Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer 2026-06-22 · Pfizer Pfizer Announces Chief Financial Officer Transition 2026-06-18 · Pfizer

Track PFE in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer